Product NDC: | 63323-651 |
Proprietary Name: | Adenosine |
Non Proprietary Name: | ADENOSINE |
Active Ingredient(s): | 3 mg/mL & nbsp; ADENOSINE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-651 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077133 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051123 |
Package NDC: | 63323-651-04 |
Package Description: | 10 VIAL, SINGLE-USE in 1 TRAY (63323-651-04) > 4 mL in 1 VIAL, SINGLE-USE |
NDC Code | 63323-651-04 |
Proprietary Name | Adenosine |
Package Description | 10 VIAL, SINGLE-USE in 1 TRAY (63323-651-04) > 4 mL in 1 VIAL, SINGLE-USE |
Product NDC | 63323-651 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ADENOSINE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20051123 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | ADENOSINE |
Strength Number | 3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |